🇺🇸 FDA
Pipeline program

Inhaled Human Insulin

217-109

Phase 3 small_molecule completed

Quick answer

Inhaled Human Insulin for Diabetes Mellitus, Type 2 is a Phase 3 program (small_molecule) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).

Program details

Company
NEKTAR THERAPEUTICS
Indication
Diabetes Mellitus, Type 2
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials